Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Abstract 4960: ERp46 (thioredoxin...
Conference

Abstract 4960: ERp46 (thioredoxin domain-containing protein 5, TXND5) promotes prostate cancer growth in vitro and in vivo

Abstract

Abstract We have recently demonstrated that endoplasmic reticulum protein ERp46, a member of the protein disulfide isomerase family of oxidoreductases, TXND5, is overexpressed in human metastatic renal cell carcinoma. The expression and function of ERp46 in prostate cancer has not been studied. Using both in vitro and in vivo approaches, we explore the suitability of ERp46 as a potential therapeutic target in prostate cancer.

Authors

Pinthus JH; Hopmans SN; Federov S; Duivenvoorden WC

Volume

75

Pagination

pp. 4960-4960

Publisher

American Association for Cancer Research (AACR)

Publication Date

August 1, 2015

DOI

10.1158/1538-7445.am2015-4960

Conference proceedings

Cancer Research

Issue

15_Supplement

ISSN

0008-5472